沐舒坦联合利巴韦林治疗小儿支气管肺炎疗效分析  

The clinical analysis of mucosolvan combined with virazol in treating bronchopneumonia in children

作　　者：邓鸣林[1] 杨建[2] 

机构地区：[1]四川省凉山彝族自治州第一人民医院ICU室,615000 [2]四川省冕宁县人民医院,615600

出　　处：《临床合理用药杂志》2009年第1期27-28,共2页Chinese Journal of Clinical Rational Drug Use

摘　　要：目的探讨治疗小儿支气管肺炎100例的临床用药疗效。方法将100例支气管肺炎患儿随机分为沐舒坦联合利巴韦林氧气雾化吸入组(试验组)60例和对照组40例(超声雾化吸入法)进行研究。结果试验组在缓解喘憋、促进哮鸣音吸收及缩短咳嗽持续时间上明显优于对照组(P<0.05),试验组总有效率为96.7%,对照组总有效率为70.0%,2组有显著性差异(P<0.01)。结论沐舒坦联合利巴韦林氧气雾化吸入治疗毛细支气管炎疗效确切,值得临床推广。Objective To explore the curative effect of clinical medication of 100 bronchopneumonia in children. Methods 100cases were divided into two groups, atomizing inhalation of Virazol and mucosolvan （ n = 60） and ultrasonic atomizing inhalation （ n = 40）. Results The time of disappear of symptoms such as wheezing, wheezing rale, cough in treatment group was superior to those of the control group significantly. The effect of treatment group was better than that of the control group （P 〈 0. 05）. There was statical difference between two groups （P 〈 0. 01 ）. Conclusion The method of atomizing inhalation of virazol and mucosolvan has an exact effect on bronchopneumonia in children, and has a certain value for clinical generalization.

关 键 词：沐舒坦联合利巴韦林氧气雾化吸入 小儿支气管肺炎 

分 类 号：R725.6[医药卫生—儿科]